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Abstract
Active myofascial trigger points are one of the major peripheral pain generators for regional and generalized
musculoskeletal pain conditions. Myofascial trigger points are also the targets for acupuncture and/or dry needling
therapies. Recent evidence in the understanding of the pathophysiology of myofascial trigger points supports The
Integrated Hypothesis for the trigger point formation; however unanswered questions remain. Current evidence
shows that spontaneous electrical activity at myofascial trigger point originates from the extrafusal motor endplate.
The spontaneous electrical activity represents focal muscle fiber contraction and/or muscle cramp potentials
depending on trigger point sensitivity. Local pain and tenderness at myofascial trigger points are largely due to
nociceptor sensitization with a lesser contribution from non-nociceptor sensitization. Nociceptor and non-
nociceptor sensitization at myofascial trigger points may be part of the process of muscle ischemia associated with
sustained focal muscle contraction and/or muscle cramps. Referred pain is dependent on the sensitivity of
myofascial trigger points. Active myofascial trigger points may play an important role in the transition from
localized pain to generalized pain conditions via the enhanced central sensitization, decreased descending
inhibition and dysfunctional motor control strategy.
Introduction
Myofascial trigger points (MTPs) are hyperirritable spots
in skeletal muscle associated with palpable nodules in
the taut bands of muscle fibers. When these palpable
nodules are stimulated mechanically, local pain and
referred pain can be induced together with visible local
twitch response [1,2]. MTPs can be either active or
latent. An active MTP is one that refers pain either
locally to a large area and/or to another remote location,
the local and referred pain can be spontaneous or repro-
duced by mechanical stimulation which elicits a patient-
recognized pain. A latent MTP does not reproduce the
clinical pain complaint but may exhibit all of the fea-
tures of an active MTP to a minor degree. Myofascial
pain syndrome due to MTPs can be acute or chronic,
regional or generalized; it can also be a primary disorder
leading to local or regional pain syndromes or a second-
ary disorder as a consequence of other conditions [3].
Active MTPs contribute significantly to the regional
acute and chronic myofascial pain syndrome [2,3], such
as lateral epicondylalgia [4], headache and mechanical
neck pain [5] and temporomandibular pain disorders
[6]. Active MTPs are also the main peripheral pain gen-
erator in generalized musculoskeletal pain disorders [3],
such as fibromyalgia and whiplash syndrome [7,8].
MTPs are the targets for acupuncture and/or dry need-
ling [9] and other pain therapies. Indeed, MTP anesthe-
tization decreases both pain intensity and central
sensitization in local pain and generalized pain condi-
tions [8,10,11]. Two reviews have been published
recently focusing on the current state of knowledge of
myofascial pain syndrome associated with MTPs [12,13].
New evidence has emerged suggesting an important role
of spontaneous electrical activity (SEA) at MTPs in the
induction of muscle pain and central sensitization. This
article reviews the literatures in the last decade about
the SEA at MTPs; in particular, how SEA contributes to
the induction of local and referred pain and how active
MTPs are involved in the transition from the localized
pain to generalized pain conditions.
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Origin of the SEA
Registered with intramuscular needle electromyography
(EMG) when the muscle is at rest, SEA is one of the
characteristics of MTP [14,15]. SEA is dysfunctional
extrafusal motor endplate potential (EPP) [15], rather
than from the gamma motor units within muscle spindle.
Muscle tissue disruption is observed immediately after
the termination of exercise, such as cytoskeletal disrup-
tions, loss of myofibrillar registry and loss of cell integ-
rity as manifested by intracellular plasma fibronectin
stain, hypercontracted regions and invasion of inflam-
matory cells. In particular, muscle fiber hypercontraction
occurs adjacent to fiber plasma membrane lesions and is
associated with very short sarcomere lengths [16,17].
Prolonged or unaccustomed exercise, acute and chronic
mechanical and electrical trauma and prolonged ischemia
lead to cell membrane damage which is the initial event
in muscle damage [18,19]. Following cell membrane
damage, influx of Ca2+ is increased, leading to Ca2+ over-
load. As a result, calpains and phospholipase A2 may be
activated; production of reactive oxygen species may be
increased; and mitochondrial Ca2+ may be overloaded,
thereby further worsening the damage in a self-reinfor-
cing manner [19]. In addition to Ca2+ overload, an
increase in Na+ permeability and the accompanying
increase in Na+ influx also induce membrane depolariza-
tion [20]. Thus, mechanical trauma causes direct injury
to the cellular membrane, causing Ca2+ and Na+ to flood
the injured tissue. The Ca2+ overload contributes to the
initiation of spontaneous activity at motor endplate [21].
The localized Na+ conductance change in the membrane
of the active muscle fiber may also lead to the initiation
of spontaneous action potentials at motor endplate
[22,23]. The acetylcholine (Ach) released at a motor unit
associated with MTP may be also modulated by other
ion channels [24].
EPP, which is a local depolarization of the muscle
fibers, spreads a short distance along the muscle fibers,
with a decrement of about 50-75 per cent per milli-
meter. If the EPP exceeds a certain critical level (by
summation of successive EPPs), endplate spikes are
initiated [25], explaining the clinical phenomenon that
SEA associated with MTP is registered only in a loca-
lized spot in the muscle with intramuscular needle
EMG. Enormously increased abnormal spontaneous
release of Ach produces the SEA. SEA is a combination
of endplate noise and endplate spikes with action poten-
tials generated by sufficient amounts of spontaneously
released Ach [2,26]. Studies in MTP animal models also
show that the SEA is significantly decreased by botuli-
num toxin which inhibits the release of acetylcholine at
the neuromuscular junction [27].
Both extrafusal (alpha motor unit) and intrafusal fibers
(gamma motor unit within muscle spindle) are choliner-
gically innervated; the decrease in the SEA following
botulinum toxin application cannot differentiate the
source of SEA from the alpha motor unit or from the
gamma motor unit. The discharge patterns of static and
dynamic gamma motoneurones contribute to the con-
trol of locomotion, but contraction of the intrafusal
muscle fibers does not contribute to the force of muscle
contraction [28]. Muscle force is positively correlated
with the amplitude of EMG during dynamic contraction.
Analysis of the motor behaviors of an MTP clearly
shows that intramuscular EMG activity at an MTP
(SEA) exhibits similar motor behavior to the surface
EMG activity over an MTP and is also similar to the
intramuscular and surface EMG over a non-MTP during
voluntary muscle contractions in the upper trapezius
muscle (Figure 1), suggesting that the SEA activity dur-
ing movement contributes to the muscle force produc-
tion. Thus, this motor behavior of MTP indicates that
the SEA originates from the extrafusal motor endplate
but not from the intrafusal motor endplate. No electro-
physiological methods are currently available to record
electrical activities from intrafusal motor endplate
directly in the muscle. Instead, efferent discharges of
intrafusal motor endplate are indirectly assessed with
microneurography recorded from peripheral nerve fibers
in animals and humans. Efferent discharges of intrafusal
motor endplate are uncorrelated with any activation of
extrafusal muscle fibers in humans [29] though intrafu-
sal motor units are generally spontaneously active. How-
ever, the SEA may be recorded with intramuscular EMG
in humans and originates from extrafusal motor end-
plate in several pathophysiological conditions [30],
including MTPs [15]. SEA at MTPs may play a signifi-
cant role in the induction of pain.
Mechanisms of local and referred muscle pain
associated with MTP
Local and referred muscle pain can be consistently
induced by mechanical stimulation of active MTPs. The
local and referred pain from active MTPs can be recog-
nized by the patients as their pain experience during
daily activities (activity related pain) and/or at rest
(spontaneous pain) [31]. Active MTPs are responsible
for patient’s pain. Local and referred pain from latent
MTPs are not recognized by the patients; thus latent
MTPs are not responsible for patient’s pain.
Mechanisms of local pain and tenderness
Pressure pain threshold (PPT) measurement over an
entire muscle shows the heterogeneous distribution
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(ie the sites with the lowest PPT corresponding to the
locations of MTPs in healthy subjects), fibromyalgia [31]
and chronic tension type headache [32], indicating that
muscle nociceptors are sensitized at MTPs. The sensi-
tized nociceptors lead to an increased excitability of the
nociceptive nerve ending. In addition to the nociceptor
sensitization, non-nociceptors (mainly the large diameter
muscle afferents) are also sensitized at MTPs [33-35];
the non-nociceptors which normally do not contribute
to pain perception are now involved in pain generation
at MTPs. Thus, local pain and tenderness at MTPs are
largely due to nociceptor sensitization with a lesser con-
tribution from non-nociceptor sensitization.
Nociceptors and non-nociceptors sensitization at
MTPs is a localized event in the muscle. The algesic
substances are significantly increased at active MTP
compared with latent MTP and normal muscle point
[36]. These algesic substances may partly be released
from the peripheral sensitized nociceptors that drive the
pain associated with tissue injury [37] and may also be
released from the sustained muscle fiber contraction
[38,39] within muscle taut band [24]. A further study on
both intramuscular and surface EMG activity recorded
from an MTP for minutes revealed that the SEA was
similar to a muscle cramp potential and that the
increase in local muscle pain intensity was positively
associated with the duration and amplitude of muscle
cramp episodes [40]. The firing frequency of motor
units (14.5 ± 5.1 pulses per second) during electrically-
induced muscle cramp [41] is similar to that of the end-
plate spikes of the SEA in humans. Localized muscle
cramps may induce intramuscular hypoxia, increased
concentrations of algesic substances and direct mechani-
cal stimulation of nociceptors and pain [42,43]. Human
experimental studies showed that the irritability of a
MTP was highly correlated with the prevalence of the
SEA in the MTP as lower PPTs were associated with
higher amplitude of the SEA [44]. An increased MTP
sensitivity is associated with the occurrence of muscle
cramps [45] and glutamate injection into a latent MTP
Figure 1 An example of motor behavior of spontaneous electrical activity (SEA) of a myofascial trigger point (MTP) during trapezius
muscle contraction. The electromyographic (EMG) activity of the SEA of an MTP is similar to the surface EMG over an MTP on one side of the
upper trapezius and to both the surface and intramuscular EMG activity of a normal muscle point on the other side of the upper trapezius. Note:
following needle insertion into a MTP, surface EMG recording shows low amplitude activities.
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also increases sympathetic activity with a decreased
blood supply to the muscle and the skin [46]. Thus,
MTP pain and tenderness is closely associated with sus-
tained focal ischemia and focal muscle contraction and/
or cramps within muscle taut band. Muscle cramps may
partly underlie local and referred pain in chronic mus-
culoskeletal pain syndromes associated with active
MTPs.
Mechanisms of referred pain from MTP
Referred pain is defined as the pain the patient feels at a
remote site away from the location of an MTP. Referred
pain from active MTPs is sometimes the sole complaint
of patients with pain. A typical example is that patient
feels pain in the front shoulder only but the pain actu-
ally comes from an active MTP in the infraspinatus.
The occurrence of referred pain is dependent on the
sensitivity of an MTP. Active MTPs induce larger
referred pain area and higher pain intensity than latent
MTPs [31]. Experimental human pain studies also
showed that the maintenance of referred pain was
dependent on ongoing nociceptive input from the site of
primary muscle pain [47,48]. Animal studies showed
that sustained muscle damage might sensitize dorsal
horn neurons and open silent synapses in adjacent seg-
ments and excite neurons that supplied the body regions
in which the referred pain was felt [49]. Sustained focal
ischemia and the increased algesic substances associated
with muscle contraction and/or muscle cramps at MTP
may sensitize the dorsal horn neurons and supraspinal
structures inducing referred pain. Referred pain is a
reversible process of central sensitization or neuroplasti-
city [50] maintained by increased peripheral nociceptive
input from MTP. Inactivation of active MTP results in
the disappearance of referred pain [11]. It is important
to note that referred pain usually occurs seconds follow-
ing mechanical stimulation of an active MTP in
humans, suggesting that the induction of neuroplastic
changes related to referred pain is a very rapid process,
similar to the induction of central descending inhibition
mechanism which is recruited a few milliseconds follow-
ing intramuscular nociceptive electrical stimulation [51].
In summary, referred pain is a process of central neu-
roplasticity dynamically maintained by sustained noci-
ceptive input from MTP associated with the SEA. In
addition to the role in induction of local and referred
pain, the SEA may also contribute to the formation of
muscle taut band.
Muscle taut band
An MTP taut band is subjectively felt by the examiner
during manual palpation. Penetration of an acupuncture
needle into the taut band reveals a feeling of higher
resistance as compared to surrounding normal muscle
tissues by the practitioners. The existence of a taut band
is demonstrated by magnetic resonance elastography,
indicating that the stiffness of the taut bands may be
50% greater than that of the surrounding muscle tissue
[52]. Ultrasound visualization of the taut band show that
MTPs appear as focal, hypoechoic regions on two-
dimensional ultrasound and as focal regions of reduced
vibration amplitude on vibration sonoelastography, indi-
cating a localized, stiff nodule [53]. These findings sug-
gest that taut bands associated with MTP are detectable
and quantifiable tools for MTP diagnosis.
The mechanisms for the formation of muscle taut
band are not fully understood. The molecular mechan-
isms of taut band formation have been detailed in a
recent review [24]. SEA originates from the extrafusal
motor endplate (motor unit potential) and the SEA
represents focal muscle fiber contraction and/or muscle
cramp. Muscle fiber contraction contributes significantly
to the formation of muscle tension [54]. It is believed
that this involuntary focal muscle fiber contraction and/
or muscle cramps within taut muscle band contributes
significantly to muscle tension and to the formation of
taut band associated with MTP [24,43]. Additional con-
tributions to the formation of taut band may come from
muscle spindle afferents giving afferent signals to the
extrafusal motor unit through the H-reflex pathway
[33,55,56] and from the sympathetic facilitation to the
SEA [57] and to MTP sensitivity [58]. Sympathetic neu-
rotransmitter noradrenaline not only strengthens muscle
tone by boosting endogenous glutamate-mediated exci-
tation, but also transforms sub-threshold glutamatergic
activity into a robust excitatory drive capable of trigger-
ing motoneurone activity [59].
Thus, muscle taut band associated with MTP may
come from increased motor unit excitability with an
increased release of Ach and modulated by muscle spin-
dle afferents and sympathetic hyperactivity. One of the
peripheral pain generators in the muscle, MTP may have
generalized effects on the human nociceptive system.
Role of MTPs in the transition from localized pain
to generalized pain conditions
Apart from localized pain conditions, such as chronic
tension type headache and migraine [5], myofascial low
back pain [60], chronic prostatitis/chronic pelvic pain
syndrome in men [61], lateral epicondylalgia [4], head-
ache and mechanical neck pain [5] and temporomandib-
ular pain disorders [6], active MTPs contribute
significantly to the generalized pain conditions, such as
whiplash syndrome [8] and fibromyalgia [7,10], suggest-
ing that active MTPs play a significant role in the transi-
tion from the localized pain to generalized pain
conditions. There are several ways whereby active MTPs
may induce widespread pain or spatial pain propagation.
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Active MTPs induce central sensitization
Central sensitization mechanisms are involved in both
the localized and generalized chronic pain conditions.
Descending facilitatory and inhibitory mechanisms are
involved in acute muscle nociception [62]. Persistent
pain from tissue injury or inflammation contributes sig-
nificantly to the induction of central sensitization and
results in an enhanced net descending facilitation that
contributes to the amplification and spread of pain.
Mechanical stimulation or activation of latent MTPs
induce mechanical hyperalgesia in extrasegmental deep
tissues [40] and electrical stimulation of an active MTPs
significantly enhance somatosensory and limbic activity
in the brain [63]. Inactivation of active MTPs with con-
secutive anesthetic injections significantly decreases
mechanical hyperalgesia and/or allodynia and referred
pain in both localized pain condition of migraine [11]
and generalized pain conditions of fibromyalgia [10] and
whiplash syndrome [8]. Thus, active MTPs are one of
the sources of peripheral nociceptive input inducing
central sensitization.
Central sensitization may increase the MTP sensitivity
through segmental pathways resulting in decreased
mechanical pain threshold [64] and increased amplitude
of the SEA [65]. The influence of a central MTP on
satellite MTPs may play a significant role in the seg-
mental pain propagation in chronic generalized pain
conditions; however, no evidence supports that central
sensitization can induce the development of new MTPs.
Further studies are needed to investigate the relationship
between central sensitization and the MTP formation.
Active MTPs impair descending inhibition
In chronic musculoskeletal pain conditions, the balance
between supraspinal facilitation and inhibition of pain
shifts towards an overall decrease in inhibition. Muscle
pain impairs diffuse noxious inhibitory control mechan-
isms [66]. Inactivation of active MTPs with ultrasound
and dry needling temporarily increases mechanical pain
threshold in local pain syndromes [67,68]. Inactivation
of active MTPs results in an increased mechanical pain
threshold in fibromyalgia patients [10]. Active MTPs are
one of the major contributors to the impaired descend-
ing inhibition in chronic musculoskeletal pain condi-
tions. Impaired descending inhibition in chronic
musculoskeletal pain conditions, which is same as an
enhanced central sensitization, leads to an increased
mechanical pain sensitivity of muscle tissue (ie muscle
becomes more tender upon mechanical stimulation).
Related to this mechanism, PPT at latent MTPs located
in various body parts may become lower; latent MTPs
are easily activated in response to various perpetuating
factors. Pain propagation may thus be observed in the
segmental and/or extrasegmental muscles in generalized
chronic pain conditions.
Active MTPs impair motor control strategy
Upper trapezius muscle is active across the duration of
shoulder activities and the frequency of differential acti-
vation between cranial and caudal regions within the
upper trapezius is lower in fibromyalgia patients than
controls [69,70]. Sustained muscle activation induces
muscle ischemia [71] and increases the release of algesic
substances in the muscle and cytokines in the blood
[39,72] and eventually decreases the muscle mechanical
pain threshold more in the cranial region than the cau-
dal region. Sustained muscle contraction at low load
levels may damage muscle tissues and increase MTP
sensitivity and latent MTPs may be activated and result
in local and referred pain. An increased muscle co-acti-
vation has also been observed in local pain conditions,
such as tension type headache [73]. An increased co-
activation of antagonist musculature may reflect reorga-
nization of the motor control strategy in patients, poten-
tially leading to muscle overload and increased
nociception. While active MTPs are present in these
patients, there is no direct evidence on whether the
impaired motor control strategy is associated with the
existence of active MTPs. However, latent MTPs are
associated with impaired motor activation pattern and
the elimination of these latent MTPs induces normaliza-
tion of the impaired motor activation pattern [74,75].
The impaired motor control strategy may partially
underlie the induction of local pain and segmental pain
propagation.
Conclusion
SEA at the MTP arises from the extrafusal motor end-
plate, representing focal muscle fiber contraction and/or
muscle cramp potentials within taut band. The sustained
focal muscle fiber contraction and/or muscle cramp
potentials contribute to the induction of local and
referred pain. Active MTPs may play an important role
in the transition from the localized pain to generalized
pain conditions via the enhanced central sensitization,
decreased descending inhibition and dysfunctional
motor control strategy.
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